Cite

HARVARD Citation

    Miller, R. et al. (2022). Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre‐specified and post hoc analyses. Muscle & nerve. 66 (1), pp. 39-49. [Online]. 
  
Back to record